Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.24613 | 50 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.15616 | 49 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.16632 | 49 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.06856 | 48 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.15093 | 50 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.3066 | 50 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.28334 | 50 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.13019 | 48 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.10048 | 47 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.12764 | 48 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.15593 | 49 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.09838 | 48 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.17412 | 49 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.15487 | 49 |